Clinically, this resulted in at least ameliorating the impact of beginning psychosis on those patients affected, and providing care for the high number of clinically ill at-risk patients possibly not making transition into manifest psychosis. Last but not least, high numbers of first episode patients are detected by early recognition of psychotic disorders units, thus further reducing the duration of untreated psychosis (DUP).

Potential end-users are governmental and non-governmental agencies and organizations, clinicians and researchers in the areas of mental health care and policy, as well as the respective patient groups and their relatives.

As the main benefit, the acquired know-how will help to implement and sustain early detection and prevention programmes adapted to European and non-European mental health care systems and the needs of the help-seeking individuals.

Reported by

University Hospital of Cologne, Department of Psychiatry and Psychotherapy